Pediatric Neurocysticercosis: Usefulness of Antibody Response in Cysticidal Treatment Follow-Up

Table 1

Number of serum samples positive before the treatment, at 3–6 and 12 months following the treatment with the use of *CSE, **ES, and ***LMM antigens.

Antigen	(%)
	Before Rx	3–6 months	12 months
*CSE	14^a (42.4)	5^b (15.1)	5^c (15.1)
**ES	22^d (66.6)	2^e (6)	0^f
***LMM	11^g (33.3)	4^h (12.1)	3^i (9)

values a versus b; d versus e; g versus h; e versus f <0.05; b versus c; h versus i >0.05 (McNemar Test Exact).
*CSE: crude soluble extract; **ES: excretory secretory; ***LMM: lower molecular mass; = number studied.